CAAIF | Avir Pharma Early Investigator Research Grant in Eosinophilic Esophagitis

The Canadian Asthma, Allergy and Immunology Foundation (CAAIF) is a charitable foundation whose mission is to invest in research leading to new and better treatments that improve the lives of Canadians living with allergy, asthma and immunologic diseases.

About Avir Pharma

Avir Pharma Inc. is a wholly-owned, privately-held Canadian pharmaceutical company whose mission is to enhance the lives of Canadians through the acquisition, in-licensing and co-development of innovative, specialty pharmaceutical products. AVIR specializes in anti-infectives, gastroenterology, dermatology and pain management. Located in Blainville, Quebec, Avir Pharma Inc. is an affiliate of the Laboratoire Riva Group, an established company with over 40 years of experience in manufacturing, distributing and promoting pharmaceutical products in the Canadian marketplace. For more information, please visit the company’s web site at


  • The research must take place in Canada at a eligible institution as defined by CIHR.
  • The proposal must be completed within a 12-month period.
  • Applicants must be within the first seven (7) years (with adjustment made for career interruptions*) of completing their degree and/or training.

See Full Eligibility & Application Details

Agency Name: 
Canadian Asthma, Allergy and Immunology Foundation
Contact Name:
Grant Amount: 
Grant Location: 
External Deadline: 
Monday, November 15, 2021
Internal Deadline: 
Monday, November 8, 2021
Grant Type: 
Grant Area: 
Grant Eligibility: